| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/18/2009 | CN101385802A Traditional Chinese medicine for treating tummy, duodenal ulcer and bronchitis |
| 03/18/2009 | CN101385792A Liquor for treating disease and preparation method thereof |
| 03/18/2009 | CN101385790A Intestine moisturizing soft capsules and preparation method and use thereof |
| 03/18/2009 | CN101385788A Chinese herbal medicine preparation for treating ascitic type liver cancer |
| 03/18/2009 | CN101385783A Huganning tablets for treating chronic and urgent liver disease and preparation method thereof |
| 03/18/2009 | CN101385778A Ganjiaxin tablet |
| 03/18/2009 | CN101385774A Medicine composition for treating recurrent oral ulcer and its preparation method |
| 03/18/2009 | CN101385773A Liver clearing pill for reducing enzyme and treating jaundice and preparation method thereof |
| 03/18/2009 | CN101385770A Blueberry chrysanthemum capsules and preparation method thereof |
| 03/18/2009 | CN101385769A Blueberry pearl chewing tablet and preparation method thereof |
| 03/18/2009 | CN101385765A Compound sedum sarmentosum capsules and preparation method thereof |
| 03/18/2009 | CN101385763A Use of snow ganoderma lucidum total saponin in preparing antiviral property hepatitis medicine |
| 03/18/2009 | CN101385735A Preparation method of morroniside and new use thereof |
| 03/18/2009 | CN101385733A Composite glycyrrhizin sustained release preparation |
| 03/18/2009 | CN101385732A Low dose entecavir formulation and use |
| 03/18/2009 | CN101385717A Solid dispersion containing sofalcone as active ingredient and preparation method thereof |
| 03/18/2009 | CN101385539A Wean diet therapy method for eliminating the phlegm, cleaning the heat and nourishing the liver |
| 03/18/2009 | CN101385530A Liver-protection cola |
| 03/18/2009 | CN100469791C Glucagon-like peptide-1 analogs |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469389C Nano-grade polypeptide anti-dental caries material, producing method and tooth-paste containing said material |
| 03/18/2009 | CN100469385C Multifunctional antisenescence health product and making method thereof |
| 03/18/2009 | CN100469381C Compound capsule for decreasing alcohol and protecting liver |
| 03/18/2009 | CN100469380C Stomach motility promoting medicine for treating stomach and intestine function failure and its preparation |
| 03/18/2009 | CN100469375C Medicine for treating hepatitis and its preparing method |
| 03/18/2009 | CN100469369C Usage of stigmastane-3,5,6-triol and derivative for preparing antiviral remedy, and new stigmastane-3,5,6-triol derivatives |
| 03/18/2009 | CN100469366C Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/18/2009 | CN100469358C Deer heart powder capsule and preparation method thereof |
| 03/18/2009 | CN100469355C Nutritional supplements and methods of using same |
| 03/18/2009 | CN100469353C Balsalazide sodium enteroclyster and its preparing method |
| 03/18/2009 | CN100469255C Method for preparing bowel-lubricating, face-beautifying milk powder with micron pine pollen, cactus powder, glossy ganoderma powder and medlar |
| 03/17/2009 | US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504391 Analogues of N-methyl, hydroxy(alkoxy)-partially saturated indeno(1,2-a)-3-benzoazeines, naphtho(1,2-a)-3-benzoazepines, and 1-phenyl-3-benzazepenes; metabolic disorders/eating disorders, e.g., obesity (dietetics), hyperphagia; antidiabetic agents; obsessive compulsive, somatoform dissociative disorders |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504108 Polypeptides; immunogenic compositions; generating immune responses; kits |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/12/2009 | WO2009032885A2 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 03/12/2009 | WO2009032406A1 Dentifrice compositions for treating xerostomia |
| 03/12/2009 | WO2009032198A1 Co-crystals and pharmaceutical compositions comprising the same |
| 03/12/2009 | WO2009031922A1 Tablet for prophylaxis and treatment of dental and periodontium diseases |
| 03/12/2009 | WO2009030931A1 Compound for controlling appetite |
| 03/12/2009 | WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 03/12/2009 | WO2009009480A3 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
| 03/12/2009 | US20090069434 Cystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/12/2009 | US20090069424 TGF-alpha expression inhibitors |
| 03/12/2009 | US20090069395 Deuterium-enriched famotidine |
| 03/12/2009 | US20090069382 Bicyclic Angiotensin II Agonists |
| 03/12/2009 | US20090069376 Substituted N [N-(sulphonylphenyl)sulfonyl-prolyl]-phenylalanine derivatives are antagonists of the very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis |
| 03/12/2009 | US20090069371 Isoquinoline compounds |
| 03/12/2009 | US20090069363 Therapeutic Agent for Constipation |
| 03/12/2009 | US20090069355 Bicyclic pyrazolone cytokine inhibitors |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069247 Use of tight junction antagonists to treat inflammatory bowel disease |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090068722 produced by Paenibacillus polymyxa strain; for use in therapeutic feeds, reducing levels of colonization by target bacteria in poultry |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068261 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles |
| 03/12/2009 | US20090068199 Methods for Treating and Detecting Beta-Cell Disease |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/12/2009 | US20090068152 Gene transfer for regulating smooth muscle tone |
| 03/12/2009 | US20090068145 Methods and Compositions Relating to Islet Cell Neogenesis |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068123 Fluorine ion-releasable composition for dental purposes |
| 03/12/2009 | DE102007043056A1 Use of mannitol-dehydrogenase in medicine, for the therapy or diagnosis of disorder of fructose metabolism including fructose intolerance, to reduce bioavailability of fructose in human or animal and to produce e.g. food additive |
| 03/12/2009 | DE102007012043A1 Plant-based agent, useful for delaying and treating liver cirrhosis, comprises a mixture of vegetable oil, lovage root in powder or finely crushed form, crushed wild garlic leaves or a powder made of wild garlic leaves |
| 03/12/2009 | CA2704284A1 Co-crystals and pharmaceutical compositions comprising the same |
| 03/12/2009 | CA2698396A1 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2698377A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 03/12/2009 | CA2697930A1 Compound for controlling appetite |
| 03/12/2009 | CA2690011A1 Dentifrice compositions for treating xerostomia |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
| 03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
| 03/11/2009 | EP2032568A2 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor |
| 03/11/2009 | EP2032134A2 Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis |
| 03/11/2009 | EP2032132A2 Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury |
| 03/11/2009 | EP1696937B1 Prebiotic combination products |
| 03/11/2009 | EP1519728B1 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1411899B1 Taste masking composition |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1302476B1 Reduced fk228 and use thereof |
| 03/11/2009 | EP1294384B1 Use of lanthanum compounds for the treatment of bone diseases |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384588A Process for preparing intermediates to 5-ht4 receptor agonist compounds |